Last reviewed 2026-04-20 · How we verify

Leptin A

Pennington Biomedical Research Center · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Leptin A
Sponsor	Pennington Biomedical Research Center
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy (PHASE2)
Physical Exercise and Biomolecular Analysis to Reduce Uremic Toxins in Chronic Kidney Disease: An Exploratory Study (NA)
The Influence of Non-Caloric Artificial Sweeteners on Youth With Type 1 Diabetes
A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults (PHASE3)
Effect of a Low-Calorie MCT-Rich Traditional Minangkabau Diet on Obese Individuals (NA)
Hunger Perception and Weight-Related Outcomes Following Use of a Leptin-Supporting Dietary Supplement (NA)
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy (PHASE3)
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results